Skip to main content
. 2021 Jan 1;13(1):e2021015. doi: 10.4084/MJHID.2021.015

Table 2.

Clinical and laboratory findings in patients with COVID-19.

All patients(n=39) D-dimer_L(n=30) D-dimer_H(n=9) p-value
Characteristics
Age(years) 49.0(31.0–56.0) 49.0(24.5–55.3) 54.0(47.0–74.5) 0.030
Gender
Male(n[%]) 19[48.7] 15[50.0] 4[44.4] 1.000
Female(n[%]) 20[51.3] 15[50.0] 5[55.6] 1.000
Chronic medical illness
CVD(n[%]) 3[7.7] 1[3.3] 2[22.2] 0.127
Current Smokers(n[%]) 4[10.3] 3[10.0] 1[11.1] 1.000
Diabetes(n[%]) 4[10.3] 2[6.7] 2[22.2] 0.223
length of stay(days) 12.0±4.3 10.7±3.6 16.0±4.2 0.001
CT scores on admission 9(5–11) 9(5–11) 10(9–15) 0.022
Laboratory Findings
Leucocytes(×109 /L) 6.27(4.64–7.82) 5.70(4.34–7.42) 7.55(5.47–8.80) 0.096
Lymphocytes(×109 /L) 1.16(0.84–1.68) 1.28(1.02–1.74) 1.04(0.59–1.42) 0.194
Neutrophils(×109 /L) 3.52(2.91–4.44) 3.23(1.92–4.17) 5.20(3.66–7.19) 0.002
NLR 2.59 (1.86–4.28) 2.35(1.72–3.71) 6.19(2.79–9.79) 0.014
Monocytes(×109 /L) 0.46(0.33–0.52) 0.46(0.35–0.51) 0.51(0.27–0.58) 0.920
LDL-C(mmol/L) 1.88(1.55–2.34) 1.85(1.55–2.35) 1.95(1.46–2.33) 0.764
Triglycerides (mmol/L) 1.09(0.93–1.58) 1.24(0.95–1.60) 0.95(0.83–1.07) 0.072
Total-cholesterol(mmol/L) 3.87±0.95 3.82±0.90 4.04±1.00 0.546
C-reaction protein(mg/L) 3.50(0.50–16.50) 1.59(0.50–5.66) 38.88(13.60–66.60) 0.001
ESR(mm/h) 22.0(12.0–39.5) 19.5(10.6–29.4) 41.7(27.0–76.8) 0.002
D-dimer(mg/L) 0.43(0.19–0.88) 0.35(0.15–0.52) 4.49(1.55–7.00) 0.000

Data are expressed as median (IQR), mean ± standard deviation or number[%]. Between group comparisons of continuous variables were analyzed by independent sample t-tests or Mann-Whitney U-tests, and comparisons of categorical variables by chi-square tests.

Abbreviations: COVID-19=coronavirus disease 2019; CVD=cardiovascular disease; NLR= neutrophil-lymphocyte ratio; LDL-C=low-density lipoprotein cholesterol; ESR=erythrocyte sedimentation rate; NLR: neutrophil-lymphocyte ratio.